Delivery Order SPE2DR25D1004-SPE2DR26FSVB0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,930.10 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) on October 14, 2025, with an ultimate completion date of October 15, 2025. This firm fixed-price, competitively awarded delivery order represents fulfillment under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) with a ceiling value of $16,639.53. This firm fixed-price delivery order was issued on November 7, 2025, with an ultimate completion date of November 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,976.56 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count packaging) valued at $6,334.82 under a firm fixed-price contract. The award was issued on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-competitive set-aside delivery against the company's larger indefinite delivery contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) with a ceiling value of $17,319.74. This firm fixed-price delivery order, awarded on July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.24 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,783.59 on November 12, 2025, for the supply of Veozah 45 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of November 13, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $16,687.51 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets in a quantity of 30 units, valued at $2,465.73. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,746.14 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count packaging) with a completion date of November 10, 2025. This non-competitive, firm fixed-price delivery order was issued on November 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSVB0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,986.03 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count supply). This firm fixed-price, non-set-aside contract was awarded on November 17, 2025, with an ultimate completion date of November 18, 2025. The award represents a direct delivery order against AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999 through December 2026. Performance will be executed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical support role within the federal medical supply chain, serving military healthcare systems and other government agencies. As the prime contractor on the DLA Troop Support Medical IDC, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The Veozah delivery is consistent with the company's demonstrated capability to fulfill federal pharmaceutical procurement requirements through open competition and represents the type of individual therapeutic medication deliveries that support the Defense Health Agency and broader military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 11/17/25 |